Washington, DC - A secondary analysis of the Hemodialysis (HEMO) Study highlights the significant biases in trial results that can occur when as-treated vs intention-to-treat methodology is applied [ ...

Please provide your email address to receive an email when new articles are posted on . Average annual injectable drug expenditures for in-center hemodialysis were $20,000. Total annual costs were ...

The most comprehensive, randomized clinical trial of hemodialysis therapy to-date has confirmed the adequacy of current dosage guidelines. The researchers also found that using high-flux filters to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The Patient-Centered Outcomes Research Institute (PCORI ...

Please provide your email address to receive an email when new articles are posted on . Researchers found it feasible for patients with incident kidney dysfunction requiring dialysis to receive ...

The Patient-Centered Outcomes Research Institute (PCORI) recently awarded researchers at Wake Forest University School of Medicine $10.2 million to study the effectiveness of an individualized model ...

For hemodialysis patients, undergoing dialysis for eight hours overnight, three times weekly, reduces the risk of death by nearly 80 percent, compared to conventional, four-hour dialysis, according to ...

A new study reveals that hemodialysis may reduce blood flow to the brain in older patients being treated for kidney failure. The findings, which appear in an upcoming issue of the Journal of the ...

This Practice Point commentary discusses the findings and limitations of a cohort study reported by Wald and colleagues of mineral metabolism in patients on hemodialysis. The investigators' ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx ...